ILC3s promote intestinal tuft cell hyperplasia and anthelmintic immunity through RANK signaling
Science Immunology · 2025
DOI: 10.1126/sciimmunol.adn1491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2025. Verfasst von Hongkai Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunology, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: Receptor Activator of Nuclear Factor-kappa B, Lymphocytes, Helminthiasis, Intestinal Mucosa. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
Helminth infections, particularly in developing countries, remain a notable health burden worldwide. Group 3 innate lymphoid cells (ILC3s) are enriched in the intestine and play a critical role in immunity against extracellular bacteria and fungi. However, whether ILC3s are involved in intestinal helminth infection is still unclear. Here, we report that helminth infection reprograms ILC3s, which, in turn, promote anthelmintic immunity. ILC3-derived RANKL [receptor activator of NF-κB (nuclear factor κB) ligand] synergizes with interleukin-13 (IL-13) to facilitate intestinal tuft cell expansion after helminth infection, which further activates the tuft cell–group 2 innate lymphoid cell (ILC2) circuit to control helminth infection. Deletion of RANKL in ILC3s or deletion of RANK or its downstream adaptor RelB in intestinal epithelial cells substantially diminishes tuft cell hyperplasia and dampens anthelmintic immunity. Thus, ILC3s play an indispensable role in protecting against helminth infection through the regulation of intestinal tuft cell hyperplasia and type 2 immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Immunology, Tsinghua University, Beijing 100084, China.
- School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing 100084, China.
- Beijing Key Laboratory of Immunological Research of Allergy (LIRA), Tsinghua University, Beijing 100084, China.
- State Key Laboratory of Molecular Oncology, School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China.
- CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, S…
- Westlake University, Hangzhou 310030, China.
ORCID-Profile: Hongkai Xu, Yibo Wang, Wenyan Wang, Yang-Xin Fu, Yan Shi, Chen Dong, Xiaoyu Hu, Ye-Guang Chen, Xiaohuan Guo
Zitieren
APA
Xu, H., Wang, Y., Wang, W., Fu, Y. X., Qiu, J., Shi, Y., Yuan, L., Dong, C., Hu, X., Chen, Y. G., & Guo, X. (2025). ILC3s promote intestinal tuft cell hyperplasia and anthelmintic immunity through RANK signaling. Science Immunology. https://doi.org/10.1126/sciimmunol.adn1491
Vancouver
Xu H, Wang Y, Wang W, Fu YX, Qiu J, Shi Y, et al. ILC3s promote intestinal tuft cell hyperplasia and anthelmintic immunity through RANK signaling. Science Immunology. 2025. doi:10.1126/sciimmunol.adn1491
BibTeX
@article{Xu2025,
author = {Xu, Hongkai and Wang, Yibo and Wang, Wenyan and Fu, Yang-Xin and Qiu, Ju and Shi, Yan and Yuan, Lei and Dong, Chen and Hu, Xiaoyu and Chen, Ye-Guang and Guo, Xiaohuan},
title = {ILC3s promote intestinal tuft cell hyperplasia and anthelmintic immunity through RANK signaling},
journal = {Science Immunology},
year = {2025},
doi = {10.1126/sciimmunol.adn1491}
}
EUVIMED